Oliver FreudenreichDr. Freudenreich's academic interest lies in the area of optimal psychopharmacological treatment for schizophrenia, including the development of innovative treatments and management of treatment-resistant psychosis. In addition to his clinical and clnical trial expertise in schizophrenia, Dr. Freudenreich provides psychiatric consultations for medically complex patients with serious mental illness and for diagnostically difficult cases with psychosis. He has published extensively in his areas of interest and has written a handbook on psychotic disorders (2e published in 2020). Dr. Freudenreich teaches and speaks on a regular basis at international and national meetings. Recent awards include the MGH Department of Psychiatry Clinical Excellence Award and the 2022 Outstanding Psychiatrist Award for the Public Sector from the Massachusetts Psychiatric Society. Read More Read Less